October 10th, 2011
The Vagaries of Atrial Fibrillation
Shengshou Hu, M.D.
Dr. Wes explores the features of a “full-disclosure” patch heart monitor that doesn’t seem to miss asymptomatic arrhythmias.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?